Peter Sand to Time Factors
This is a "connection" page, showing publications Peter Sand has written about Time Factors.
Connection Strength
0.451
-
Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Urology. 2021 11; 157:71-78.
Score: 0.106
-
Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies. Drugs Aging. 2012 Feb 01; 29(2):119-31.
Score: 0.056
-
Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology. 2008 Jan; 71(1):57-61.
Score: 0.042
-
Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Repair Regen. 2007 Jan-Feb; 15(1):80-6.
Score: 0.039
-
Biomechanical characterization of vaginal versus abdominal surgical wound healing in the rabbit. Am J Obstet Gynecol. 2006 May; 194(5):1472-7.
Score: 0.037
-
Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best? Urology. 2004 Jul; 64(1):53-7.
Score: 0.033
-
Anterior Colporrhaphy With and Without Dermal Allograft: A Randomized Control Trial With Long-Term Follow-Up. Female Pelvic Med Reconstr Surg. 2019 May-Jun; 25(3):206-212.
Score: 0.023
-
Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997;49(Suppl 5A):93-99. J Womens Health. 1998 Mar; 7(2):268-9.
Score: 0.021
-
Incisional hernia after suprapubic catheterization. Obstet Gynecol. 1997 May; 89(5 Pt 2):844-6.
Score: 0.020
-
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800.
Score: 0.019
-
Can pelvic floor injury secondary to delivery be prevented? Int Urogynecol J. 2012 Feb; 23(2):165-73.
Score: 0.013
-
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms. Neurourol Urodyn. 2011 Sep; 30(7):1214-9.
Score: 0.013
-
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin. 2011 May; 27(5):921-30.
Score: 0.013
-
Effect of parity on sexual function: an identical twin study. Obstet Gynecol. 2006 Apr; 107(4):765-70.
Score: 0.009
-
Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
Score: 0.007